×
Cano Health EBITDA 2020-2024 | CANOQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cano Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Cano Health EBITDA 2020-2024 | CANOQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cano Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$141.5B
CVS Health (CVS)
$81.4B
Elevance Health (ELV)
$76.8B
Cencora (COR)
$57.6B
DiDi Global (DIDIY)
$25.2B
Natera (NTRA)
$21.6B
Labcorp Holdings (LH)
$20.9B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.3B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.8B
ICON (ICLR)
$12.1B
Revvity (RVTY)
$11.6B
Viatris (VTRS)
$10.7B
Medpace Holdings (MEDP)
$9.2B
Avantor (AVTR)
$9B
Sonic Healthcare (SKHHY)
$8.8B
HealthEquity (HQY)
$8.4B
Charles River Laboratories (CRL)
$7.8B
Caris Life Sciences,�Inc (CAI)
$7.1B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.8B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.3B
Surgery Partners (SGRY)
$2.9B
Alignment Healthcare (ALHC)
$2.7B
Concentras Parent (CON)
$2.6B
Organon (OGN)
$2.6B
GeneDx Holdings (WGS)
$2.4B
Ardent Health (ARDT)
$2.1B